-
1
-
-
0032495853
-
Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents
-
DOI 10.1001/jama.279.14.1100
-
Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. J Am Med Asoc 1998; 279: 1100-1107. (Pubitemid 28177819)
-
(1998)
Journal of the American Medical Association
, vol.279
, Issue.14
, pp. 1100-1107
-
-
Goldman, L.S.1
Genel, M.2
Bezman, R.J.3
Slanetz, P.J.4
Karlan, M.S.5
Davis, R.M.6
Altman, R.D.7
Bezman, R.J.8
Deitchman, S.D.9
Genel, M.10
Howe III, J.P.11
Nielsen, N.H.12
Riggs, J.A.13
Field, H.14
Slanetz, P.J.15
Williams, M.A.16
Young, D.C.17
Goldman, L.S.18
Rinaldi, R.C.19
Bresolin, L.20
more..
-
3
-
-
0347419387
-
Long-Term Use of Stimulants in Children with Attention Deficit Hyperactivity Disorder: Safety, Efficacy, and Long-Term Outcome
-
DOI 10.2165/00148581-200305120-00002
-
Hechtman L, Greenfield B. Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome. Paediatr Drugs 2003; 5: 787-794. (Pubitemid 38030604)
-
(2003)
Pediatric Drugs
, vol.5
, Issue.12
, pp. 787-794
-
-
Hechtman, L.1
Greenfield, B.2
-
4
-
-
3042622074
-
Clinical practice guideline: Treatment of the school-aged child with attentiondeficit/ hyperactivity disorder
-
American Academy of Pediatrics SoA-DHD
-
American Academy of Pediatrics SoA-DHD. Clinical practice guideline: treatment of the school-aged child with attentiondeficit/ hyperactivity disorder. Pediatrics 2001; 108: 1033-1044.
-
(2001)
Pediatrics
, vol.108
, pp. 1033-1044
-
-
-
5
-
-
43249096555
-
Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: A scientific statement from the American Heart Association Council on cardiovascular disease in the Young Congenital Cardiac Defects Committee and the Council On Cardiovascular Nursing
-
DOI 10.1161/CIRCULATIONAHA.107.189473, PII 0000301720080506000016
-
Vetter VL, Elia J, Erickson C, et al. Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing. Circulation 2008; 117: 2407-2423. (Pubitemid 351653546)
-
(2008)
Circulation
, vol.117
, Issue.18
, pp. 2407-2423
-
-
Vetter, V.L.1
Elia, J.2
Erickson, C.3
Berger, S.4
Blum, N.5
Uzark, K.6
Webb, C.L.7
-
6
-
-
51249120774
-
-
American Academy of Pediatrics/American Heart Association clarification of statement on cardiovascular evaluation and monitoring of children and adolescents with heart disease receiving medications for ADHD: May 16, 2008
-
American Academy of Pediatrics/American Heart Association clarification of statement on cardiovascular evaluation and monitoring of children and adolescents with heart disease receiving medications for ADHD: May 16, 2008. J Dev Behav Pediatr 2008; 29: 335.
-
(2008)
J Dev Behav Pediatr
, vol.29
, pp. 335
-
-
-
7
-
-
84857468770
-
-
Disorders ENoH. EUNETHYDIS ADHD Drug Safety Meeting. Paper presented at, 10-13 March, Zurich
-
Disorders ENoH. EUNETHYDIS ADHD Drug Safety Meeting. Paper presented at EUNETHYDIS ADHD Drug Safety Meeting, 10-13 March, 2009, Zurich.
-
(2009)
EUNETHYDIS ADHD Drug Safety Meeting
-
-
-
8
-
-
4344603965
-
Sudden cardiac death in children and adolescents: Introduction and overview
-
DOI 10.1016/j.pcl.2004.04.008, PII S0031395504000574
-
Berger S, Kugler JD, Thomas JA, Friedberg DZ. Sudden cardiac death in children and adolescents: introduction and overview. Pediatr Clin North Am 2004; 51: 1201-1209. (Pubitemid 39149778)
-
(2004)
Pediatric Clinics of North America
, vol.51
, Issue.5
, pp. 1201-1209
-
-
Berger, S.1
Kugler, J.D.2
Thomas, J.A.3
Friedberg, D.Z.4
-
9
-
-
0032491031
-
Screening for hypertrophic cardiomyopathy in young athletes
-
DOI 10.1056/NEJM199808063390602
-
Corrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998; 339: 364-369. (Pubitemid 28363798)
-
(1998)
New England Journal of Medicine
, vol.339
, Issue.6
, pp. 364-369
-
-
Corrado, D.1
Basso, C.2
Schiavon, M.3
Thiene, G.4
-
10
-
-
0021934627
-
Sudden and unexpected natural death in childhood and adolescence
-
DOI 10.1001/jama.254.10.1321
-
Neuspiel DR, Kuller LH. Sudden and unexpected natural death in childhood and adolescence. J Am Med Assoc 1985; 254: 1321-1325. (Pubitemid 15236604)
-
(1985)
Journal of the American Medical Association
, vol.254
, Issue.10
, pp. 1321-1325
-
-
Neuspiel, D.R.1
Kuller, L.H.2
-
11
-
-
33646855404
-
ADHD drugs and cardiovascular risk
-
author reply 2296-2298
-
Rappley MD, Moore JW, Dokken D. ADHD drugs and cardiovascular risk. N Engl J Med 2006; 354: 2296-2298; author reply 2296-2298.
-
(2006)
N Engl J Med
, vol.354
, pp. 2296-2298
-
-
Rappley, M.D.1
Moore, J.W.2
Dokken, D.3
-
12
-
-
0034024150
-
Sudden death in children and adolescents
-
Wren C. Sudden death in children and adolescents. Heart 2000; 83: 410-413. (Pubitemid 30316754)
-
(2000)
Heart
, vol.83
, Issue.4
, pp. 410-413
-
-
Wren, C.1
O'Sullivan, J.J.2
Wright, C.3
-
13
-
-
0032127172
-
A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects
-
DOI 10.1016/S0735-1097(98)00187-9, PII S0735109798001879
-
Silka MJ, Hardy BG, Menashe VD, Morris CD. A populationbased prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol 1998; 32: 245-251. (Pubitemid 28351069)
-
(1998)
Journal of the American College of Cardiology
, vol.32
, Issue.1
, pp. 245-251
-
-
Silka, M.J.1
Hardy, B.G.2
Menashe, V.D.3
Morris, C.D.4
-
14
-
-
34547200411
-
Epidemiology of attention-deficit/hyperactivity disorder in the community
-
Sayal K. Epidemiology of attention-deficit/hyperactivity disorder in the community. Br J Hosp Med (Lond) 2007; 68: 352-355. (Pubitemid 47121456)
-
(2007)
British Journal of Hospital Medicine
, vol.68
, Issue.7
, pp. 352-355
-
-
Sayal, K.1
-
15
-
-
32644463729
-
Long-term neurodevelopmental outcome and exercise capacity after corrective surgery for tetralogy of Fallot or ventricular septal defect in infancy
-
DOI 10.1016/j.athoracsur.2005.09.010, PII S0003497505016073
-
Hovels-Gurich HH, Konrad K, Skorzenski D, et al. Long-term neurodevelopmental outcome and exercise capacity after corrective surgery for tetralogy of Fallot or ventricular septal defect in infancy. Ann Thorac Surg 2006; 81: 958-966. (Pubitemid 43247667)
-
(2006)
Annals of Thoracic Surgery
, vol.81
, Issue.3
, pp. 958-966
-
-
Hovels-Gurich, H.H.1
Konrad, K.2
Skorzenski, D.3
Nacken, C.4
Minkenberg, R.5
Messmer, B.J.6
Seghaye, M.-C.7
-
16
-
-
42949177616
-
Inattention, hyperactivity, and school performance in a population of school-age children with complex congenital heart disease
-
Shillingford AJ, Glanzman MM, Ittenbach RF, Clancy RR, Gaynor JW, Wernovsky G. Inattention, hyperactivity, and school performance in a population of school-age children with complex congenital heart disease. Pediatrics 2008; 121: e759-e767.
-
(2008)
Pediatrics
, vol.121
-
-
Shillingford, A.J.1
Glanzman, M.M.2
Ittenbach, R.F.3
Clancy, R.R.4
Gaynor, J.W.5
Wernovsky, G.6
-
17
-
-
36849078855
-
Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder
-
DOI 10.1542/peds.2007-0675
-
Winterstein AG, Gerhard T, Shuster J, Johnson M, Zito JM, Saidi A. Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics 2007; 120: e1494-e1501. (Pubitemid 350223669)
-
(2007)
Pediatrics
, vol.120
, Issue.6
-
-
Winterstein, A.G.1
Gerhard, T.2
Shuster, J.3
Johnson, M.4
Zito, J.M.5
Saidi, A.6
-
18
-
-
69949090591
-
Sudden death and use of stimulant medications in youths
-
Gould MS,Walsh BT, Munfakh JL, et al. Sudden death and use of stimulant medications in youths. Am J Psychiatry 2009; 166: 992-1001.
-
(2009)
Am J Psychiatry
, vol.166
, pp. 992-1001
-
-
Gould, M.S.1
Walsh, B.T.2
Munfakh, J.L.3
-
19
-
-
68849086665
-
Stimulant use linked to sudden death in children without heart problems
-
Kuehn BM. Stimulant use linked to sudden death in children without heart problems. J Am Med Assoc 2009; 302: 613-614.
-
(2009)
J Am Med Assoc
, vol.302
, pp. 613-614
-
-
Kuehn, B.M.1
-
20
-
-
79957880103
-
Cardiovascular events and death in children exposed and unexposed to ADHD agents
-
Schelleman H, Bilker WB, Strom BL, et al. Cardiovascular events and death in children exposed and unexposed to ADHD agents. Pediatrics 2011; 127: 1102-1110.
-
(2011)
Pediatrics
, vol.127
, pp. 1102-1110
-
-
Schelleman, H.1
Bilker, W.B.2
Strom, B.L.3
-
21
-
-
0034067414
-
The preclinical assessment of the risk for QT interval prolongation
-
Champeroux P, Martel E, Vannier C, et al. The preclinical assessment of the risk for QT interval prolongation. Thérapie 2000; 55: 101-109. (Pubitemid 30319265)
-
(2000)
Therapie
, vol.55
, Issue.1
, pp. 101-109
-
-
Champeroux, P.1
Martel, E.2
Vannier, C.3
Blanc, V.4
Leguennec, J.-Y.5
Fowler, J.6
Richard, S.7
-
22
-
-
0028606736
-
Drug-induced torsade de pointes. Incidence, management and prevention
-
Faber TS, Zehender M, Just H. Drug-induced torsade de pointes. Incidence, management and prevention. Drug Saf 1994; 11: 463-476.
-
(1994)
Drug Saf
, vol.11
, pp. 463-476
-
-
Faber, T.S.1
Zehender, M.2
Just, H.3
-
24
-
-
34250331569
-
QTc-prolonging drugs and the risk of sudden death
-
Reingardiene D, Vilcinskaite J. QTc-prolonging drugs and the risk of sudden death. Medicina (Kaunas) 2007; 43: 347-353.
-
(2007)
Medicina (Kaunas)
, vol.43
, pp. 347-353
-
-
Reingardiene, D.1
Vilcinskaite, J.2
-
25
-
-
0043124593
-
Cardiovascular effects of atomoxetine in children, adolescents, and adults
-
DOI 10.2165/00002018-200326100-00006
-
Wernicke JF, Faries D, Girod D, et al. Cardiovascular effects of atomoxetine in children, adolescents, and adults. Drug Saf 2003; 26: 729-740. (Pubitemid 36976134)
-
(2003)
Drug Safety
, vol.26
, Issue.10
, pp. 729-740
-
-
Wernicke, J.F.1
Faries, D.2
Girod, D.3
Brown, J.W.4
Gao, H.5
Kelsey, D.6
Quintana, H.7
Lipetz, R.8
Michelson, D.9
Heiligenstein, J.10
-
26
-
-
0036929584
-
Safety profile of atomoxetine in the treatment of children and adolescents with ADHD
-
Wernicke JF, Kratochvil CJ. Safety profile of atomoxetine in the treatment of children and adolescents with ADHD. J Clin Psychiatry 2002; 63 (Suppl 12): 50-55. (Pubitemid 36025588)
-
(2002)
Journal of Clinical Psychiatry
, vol.63
, Issue.SUPPL. 12
, pp. 50-55
-
-
Wernicke, J.F.1
Kratochvil, C.J.2
-
27
-
-
0034096534
-
Cost effectiveness analysis of screening of high school athletes for risk of sudden cardiac death
-
Fuller CM. Cost effectiveness analysis of screening of high school athletes for risk of sudden cardiac death. Med Sci Sports Exerc 2000; 32: 887-890. (Pubitemid 30230667)
-
(2000)
Medicine and Science in Sports and Exercise
, vol.32
, Issue.5
, pp. 887-890
-
-
Fuller, C.M.1
-
28
-
-
77949808400
-
Modeled economic evaluation of alternative strategies to reduce sudden cardiac death among children treated for attention deficit/ hyperactivity disorder
-
Denchev P, Kaltman JR, Schoenbaum M, Vitiello B. Modeled economic evaluation of alternative strategies to reduce sudden cardiac death among children treated for attention deficit/ hyperactivity disorder. Circulation 2010; 121: 1329-1337.
-
(2010)
Circulation
, vol.121
, pp. 1329-1337
-
-
Denchev, P.1
Kaltman, J.R.2
Schoenbaum, M.3
Vitiello, B.4
-
29
-
-
30344476117
-
Usefulness and cost effectiveness of cardiovascular screening of young adolescents
-
DOI 10.1249/01.mss.0000183187.88000.53
-
Tanaka Y, Yoshinaga M, Anan R, et al. Usefulness and cost effectiveness of cardiovascular screening of young adolescents. Med Sci Sports Exerc 2006; 38: 2-6. (Pubitemid 43062949)
-
(2006)
Medicine and Science in Sports and Exercise
, vol.38
, Issue.1
, pp. 2-6
-
-
Tanaka, Y.1
Yoshinaga, M.2
Anan, R.3
Tanaka, Y.4
Nomura, Y.5
Oku, S.6
Nishi, S.7
Kawano, Y.8
Tei, C.9
Arima, K.10
-
30
-
-
33749367428
-
Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program
-
DOI 10.1001/jama.296.13.1593
-
Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. J Am Med Assoc 2006; 296: 1593-1601. (Pubitemid 44515020)
-
(2006)
Journal of the American Medical Association
, vol.296
, Issue.13
, pp. 1593-1601
-
-
Corrado, D.1
Basso, C.2
Pavei, A.3
Michieli, P.4
Schiavon, M.5
Thiene, G.6
-
31
-
-
0029979686
-
Cost-effectiveness analysis in a setting of budget constraints: Is it equitable?
-
DOI 10.1056/NEJM199605023341807
-
Ubel PA, DeKay ML, Baron J, Asch DA. Cost-effectiveness analysis in a setting of budget constraints - is it equitable? N Engl J Med 1996; 334: 1174-1177. (Pubitemid 26137978)
-
(1996)
New England Journal of Medicine
, vol.334
, Issue.18
, pp. 1174-1177
-
-
Ubel, P.A.1
Dekay, M.L.2
Baron, J.3
Asch, D.A.4
-
33
-
-
29944434794
-
Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: A double-blind, randomized, cross-over trial
-
DOI 10.1007/s00467-005-2051-1
-
Samuels JA, Franco K, Wan F, Sorof JM. Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial. Pediatr Nephrol 2006; 21: 92-95. (Pubitemid 43040200)
-
(2006)
Pediatric Nephrology
, vol.21
, Issue.1
, pp. 92-95
-
-
Samuels, J.A.1
Franco, K.2
Wan, F.3
Sorof, J.M.4
-
34
-
-
84857465149
-
-
European Medicines Agency%. European Medicine Agency, 7 Westferry Circus, Canary Wharf, London E14 4HB, UK
-
European Medicines Agency%. Guideline on Clinical Investigation of Medicinal Products for the Treatment of Attention Deficit Hyperactivity Disorder (ADHD), 2009. European Medicine Agency, 2010. 7 Westferry Circus, Canary Wharf, London E14 4HB, UK.
-
(2010)
Guideline on Clinical Investigation of Medicinal Products for the Treatment of Attention Deficit Hyperactivity Disorder (ADHD), 2009
-
-
-
35
-
-
0033596691
-
Cardiovascular monitoring of children and adolescents receiving psychotropic drugs: A statement for healthcare professionals from the committee on congenital cardiac defects, council on cardiovascular disease in the young, American Heart Association
-
Gutgesell H, Atkins D, Barst R, et al. Cardiovascular monitoring of children and adolescents receiving psychotropic drugs: a statement for healthcare professionals from the Committee on Congenital Cardiac Defects, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 1999; 99: 979-982. (Pubitemid 29094318)
-
(1999)
Circulation
, vol.99
, Issue.7
, pp. 979-982
-
-
Gutgesell, H.1
Atkins, D.2
Barst, R.3
Buck, M.4
Franklin, W.5
Humes, R.6
Ringel, R.7
Shaddy, R.8
Taubert, K.A.9
-
36
-
-
70449120823
-
Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder
-
Spencer TJ, Greenbaum M, Ginsberg LD, Murphy WR. Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2009; 19: 501-510.
-
(2009)
J Child Adolesc Psychopharmacol
, vol.19
, pp. 501-510
-
-
Spencer, T.J.1
Greenbaum, M.2
Ginsberg, L.D.3
Murphy, W.R.4
-
37
-
-
70350454952
-
Management of high blood pressure in children and adolescents: Recommendations of the European Society of Hypertension
-
Lurbe E, Cifkova R, Cruickshank JK, et al. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 2009; 27: 1719-1742.
-
(2009)
J Hypertens
, vol.27
, pp. 1719-1742
-
-
Lurbe, E.1
Cifkova, R.2
Cruickshank, J.K.3
|